Alcon (ALC) stock drops 10% after Q1 revenue miss; see earnings details, margin pressure, FY26 outlook and $1.5B buyback—read the key takeaways now.

Alcon shares fell around 7% on Wednesday after the Swiss eye care company reported first-quarter sales that fell short of analyst expectations, even as it raised its full-year earnings outlook.

Q1 2026 Management View "The first quarter was an important step forward for our new products, demonstrating strong market acceptance and share gains" (CEO & Director David Endicott), adding that ...

By almost any standard, Alcon, the global eyecare company with manufacturing and research facilities in Berks County, had a ...

By Simon Ferdinand Eibach Gdansk, May 6 (Reuters) - Swiss-American eye care company Alcon reported a 10% rise in its quarterly revenue, citing recent product launches as main drivers. • Alcon's net ...

Alcon's overall performance for 2025 was "below target," but the company says it needs to pay executives more to compete for ...

Joining me on today's call are David Endicott, our Chief Executive Officer; and Tim Stonesifer, our Chief Financial Officer. Before we begin, please note that our press release, presentation and ...

Investing.com -- Needham has released prescription trend data for April 2026 covering glaucoma and dry eye medications from Alcon (NYSE:ALC) and Bausch + Lomb (NYSE:BLCO), based on IQVIA tracking.

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

The company already employs thousands in Fort Worth and is a global giant in eye care, with annual revenue of more than $10 billion.

Alcon AG reports first-quarter earnings Tuesday after the close, testing whether the Swiss eye-care giant’s recent wave of product launches can sustain double-digit growth momentum even as analyst ...

GENEVA, SWITZERLAND – For the past several years Alcon has behaved like a utility company. Financial results increase at a steady 5% to 10% rate. Dividends are regular, if low. The company just keeps ...